| | | |

Top Three Factors Predicting Mesothelioma Survival are Age, Histological Type, and Surgery Status

Top Three Factors Predicting Mesothelioma Survival Malignant pleural mesothelioma is a rare and aggressive malignancy with a dismal prognosis. A new study is predicting mesothelioma survival among male and female patients in the United States.

Identifying factors “associated with mesothelioma mortality is important research given the poor prognosis” according to Dr. Bian Liu from the a Icahn School of Medicine at Mount Sinai in New York.

A new study applied a machine-learning algorithm to 12,210 patients to predict survival. The top three factors were age, histological type, and cancer-directed surgery status.

Analyzing Over 12,000 Mesothelioma Patients

Scientists from the New York State Department of Health included 12,210 mesothelioma patients. They involved only malignant pleural mesothelioma patients. They excluded cases with unknown diagnostic confirmation and unknown survival time.

Scientists identified mesothelioma cases reported by 18 cancer registries between 2000 to 2017. They applied a mathematical algorithm to identify and rank the importance of 10 variables. They ranked variables in predicting survival overall and by female and male subgroups.

Approximately 91.4% of the mesothelioma patients had died. The participant group showed better survival among females than males (11.7% vs 7.8%). The majority of the participants were male (78.6%) and non-Hispanic White (81.8%). Most participants lived in metropolitan areas with a population greater than 1 million. At cancer diagnosis, 80% of the patients were aged 65 years and above.

This study did not include some important factors known to affect mesothelioma survival. They did not include patient comorbidities. They did not include information about other therapy (e.g., chemotherapy, radiation, or multimodal therapy).

Finding the Top Three Factors Predicting Mesothelioma Survival

The top three factors predicting mesothelioma survival were age, histological type, and surgery status.

Patient age is a top factor in predicting mesothelioma survival. Next, histological type or the type of tissue in which the cancer originates. And finally, cancer-directed surgery status including those patients where surgery was not recommended.

All 10 variables except for race/ethnicity had positive variable importance. In other words, nine variables indicated they improved the survival prediction. Race/ethnicity was not a good predictor for survival among mesothelioma patients overall.

The 9 predictors (from high to low importance) were age, histology, and surgery status. Next was diagnosis year, metastasis, and summary stage. And finally, rural-urban continuum, median household income, and sex.

The cancer stage ranked fifth in predicting female survival. Median household income was not a good predictor for survival among females.

Predicting Mesothelioma Survival in Male and Female Patients

A new study identified three factors predicting mesothelioma survival. The top three factors were age, histological type, and cancer-directed surgery status.

Increased risk in mortality came from patient increasing age. Also, having fibrous or biphasic histology subtypes. Decreased mortality risk rests in patients having epithelioid histology. Also, those patients diagnosed more recently. Cancer metastasis increased the risk of dying among all patients.

Male patients with a recommendation for surgery experienced a decreased mortality risk. This was regardless of whether surgery was performed or not. However, this same association was only significant among females if the surgery was performed.

Sources

Liu, B., Niu, L., Boscoe, F., & Lee, F. F. (2021). Predictors of Survival among Male and Female Patients with Malignant Pleural Mesothelioma: A Random Survival Forest Analysis of Data from the 2000–2017 Surveillance, Epidemiology, and End Results Program. Finding Your Dream Job is Just a Click Away48(3), 118. https://www.naaccr.org/wp-content/uploads/2022/01/JRM-Fall-2021-Final.pdf#page=36

 

 

 

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…